Key result
Chronic atrial pacing linked to a ~2 mmHg drop in CVP among Fontan patients.
Why the study?
Increased heart rate can reduce central venous pressure in preserved ventricular systolic function, but whether this applies to failing Fontan physiology was unknown.
Does chronic atrial pacing improve hemodynamics and hepatorenal function in Fontan patients with sinus node dysfunction and preserved ejection fraction?
Observational (n=6)
Does chronic atrial pacing improve hemodynamics and hepatorenal function in Fontan patients with sinus node dysfunction and preserved ejection fraction?
Absolute Event Rate: 10% vs 12%
p-value: p=<0.05
Chronic atrial pacing reduces central venous pressure and ventricular volume in Fontan patients with sinus node dysfunction and preserved ejection fraction, potentially preventing end-organ dysfunction.
Hypothesis-generating for atrial pacing in Fontan patients; prospective trials needed before clinical adoption.
Increased heart rate (HR) can reduce central venous pressure (CVP) in patients with preserved ventricular systolic function. We aimed to investigate whether this theory works in failing Fontan physiology. Pacemaker implantation (PMI) was performed in six Fontan patients (age: 6–40 years) with sinus node dysfunction (SND) without junctional rhythm (JR). Baseline median (interquartile [IQR]) values of CVP, ventricular end-diastolic pressure (EDP), and ejection fraction (EF) were 12 (11–15) mmHg, 13 (10–16) mmHg, and 57% (53%–64%), respectively. Before PMI, the relationships among HR, cardiac index (L/min/m2), CVP, and EDP were evaluated using atrial pacing. Additionally, we assessed chronic changes in hemodynamics and hepatorenal function after PMI. During baseline catheterization, HR was 51 (40–58) bpm. Atrial pacing was initiated at 60 (60–63) bpm and increased to 85 (80–93) bpm. Reductions were observed in CVP (from 12 [11–15] to 9 [8–11] mmHg, p < 0.05), EDP (from 13 [10–16] to 8 [6–8] mmHg), and an increase in cardiac index (from 2.7 [2.3–3.0] to 3.4 [3.2–4.1] L/min/m2). After 1 year of PMI with HR of 80 (70–83) bpm, sustained improvements were observed, including reductions in CVP (from 12 [11–15] to 10 [9–11] mmHg, p < 0.05), EDP (from 13 [10–16] to 9 [4–9] mmHg, p = 0.06), and ventricular end-diastolic volume index (from 85 [76–98] to 67 [53–76] ml/m2, p < 0.05). Total bilirubin levels and renal resistive index also decreased (both p = 0.06). In conclusion, chronic atrial pacing therapy reduced CVP and ventricular volume in Fontan patients with preserved EF and SND, even in the absence of JR. Proactive PMI may prevent the progression of Fontan-associated end-organ dysfunction in these selected Fontan patients.
No takes yet. Share an insight, caveat, or question.
Ohuchi et al. (2025) conducted an observational in Fontan physiology with sinus node dysfunction and preserved ejection fraction (n=6). Pacemaker implantation (chronic atrial pacing) vs. Baseline was evaluated on Central venous pressure (CVP) in mmHg (p=<0.05). Chronic atrial pacing via pacemaker implantation in Fontan patients with sinus node dysfunction reduced median central venous pressure from 12 to 10 mmHg (p<0.05) at 1 year.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: